vs

Side-by-side financial comparison of CORCEPT THERAPEUTICS INC (CORT) and MIAMI INTERNATIONAL HOLDINGS, INC. (MIAX). Click either name above to swap in a different company.

MIAMI INTERNATIONAL HOLDINGS, INC. is the larger business by last-quarter revenue ($339.8M vs $202.1M, roughly 1.7× CORCEPT THERAPEUTICS INC). CORCEPT THERAPEUTICS INC runs the higher net margin — 12.0% vs -30.0%, a 42.1% gap on every dollar of revenue. On growth, MIAMI INTERNATIONAL HOLDINGS, INC. posted the faster year-over-year revenue change (22.8% vs 11.1%). MIAMI INTERNATIONAL HOLDINGS, INC. produced more free cash flow last quarter ($102.2M vs $38.4M).

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

Miami Air International was an American charter airline based in Miami-Dade County, Florida, United States. It operated worldwide passenger charter flights for diverse groups including cruise operators, professional sports teams and the United States military. It was based at Miami International Airport. Miami Air's customers included incentive groups, sports teams, Fortune 500 companies, major cruise lines, entertainers, political candidates and the United States government. Under the Civil ...

CORT vs MIAX — Head-to-Head

Bigger by revenue
MIAX
MIAX
1.7× larger
MIAX
$339.8M
$202.1M
CORT
Growing faster (revenue YoY)
MIAX
MIAX
+11.7% gap
MIAX
22.8%
11.1%
CORT
Higher net margin
CORT
CORT
42.1% more per $
CORT
12.0%
-30.0%
MIAX
More free cash flow
MIAX
MIAX
$63.8M more FCF
MIAX
$102.2M
$38.4M
CORT

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CORT
CORT
MIAX
MIAX
Revenue
$202.1M
$339.8M
Net Profit
$24.3M
$-102.1M
Gross Margin
98.7%
32.2%
Operating Margin
2.2%
-0.1%
Net Margin
12.0%
-30.0%
Revenue YoY
11.1%
22.8%
Net Profit YoY
-21.0%
-3086.0%
EPS (diluted)
$0.20
$-1.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CORT
CORT
MIAX
MIAX
Q4 25
$202.1M
Q3 25
$207.6M
$339.8M
Q2 25
$194.4M
Q1 25
$157.2M
Q4 24
$181.9M
Q3 24
$182.5M
$276.7M
Q2 24
$163.8M
Q1 24
$146.8M
Net Profit
CORT
CORT
MIAX
MIAX
Q4 25
$24.3M
Q3 25
$19.7M
$-102.1M
Q2 25
$35.1M
Q1 25
$20.5M
Q4 24
$30.7M
Q3 24
$47.2M
$-3.2M
Q2 24
$35.5M
Q1 24
$27.8M
Gross Margin
CORT
CORT
MIAX
MIAX
Q4 25
98.7%
Q3 25
97.8%
32.2%
Q2 25
98.2%
Q1 25
98.5%
Q4 24
98.4%
Q3 24
98.4%
25.1%
Q2 24
98.5%
Q1 24
98.3%
Operating Margin
CORT
CORT
MIAX
MIAX
Q4 25
2.2%
Q3 25
4.9%
-0.1%
Q2 25
13.7%
Q1 25
2.2%
Q4 24
13.9%
Q3 24
25.5%
-0.4%
Q2 24
21.7%
Q1 24
20.1%
Net Margin
CORT
CORT
MIAX
MIAX
Q4 25
12.0%
Q3 25
9.5%
-30.0%
Q2 25
18.1%
Q1 25
13.1%
Q4 24
16.9%
Q3 24
25.9%
-1.2%
Q2 24
21.7%
Q1 24
18.9%
EPS (diluted)
CORT
CORT
MIAX
MIAX
Q4 25
$0.20
Q3 25
$0.16
$-1.46
Q2 25
$0.29
Q1 25
$0.17
Q4 24
$0.25
Q3 24
$0.41
$-0.05
Q2 24
$0.32
Q1 24
$0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CORT
CORT
MIAX
MIAX
Cash + ST InvestmentsLiquidity on hand
$372.2M
$401.5M
Total DebtLower is stronger
$6.5M
Stockholders' EquityBook value
$647.8M
$831.9M
Total Assets
$836.7M
$1.2B
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CORT
CORT
MIAX
MIAX
Q4 25
$372.2M
Q3 25
$421.7M
$401.5M
Q2 25
$342.2M
Q1 25
$322.8M
Q4 24
$383.3M
Q3 24
$380.3M
$125.1M
Q2 24
$473.2M
Q1 24
$410.8M
Total Debt
CORT
CORT
MIAX
MIAX
Q4 25
Q3 25
$6.5M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CORT
CORT
MIAX
MIAX
Q4 25
$647.8M
Q3 25
$631.9M
$831.9M
Q2 25
$635.8M
Q1 25
$683.3M
Q4 24
$679.6M
Q3 24
$638.8M
$351.4M
Q2 24
$596.2M
Q1 24
$547.9M
Total Assets
CORT
CORT
MIAX
MIAX
Q4 25
$836.7M
Q3 25
$823.6M
$1.2B
Q2 25
$801.7M
Q1 25
$846.5M
Q4 24
$840.6M
Q3 24
$784.3M
Q2 24
$714.6M
Q1 24
$655.9M
Debt / Equity
CORT
CORT
MIAX
MIAX
Q4 25
Q3 25
0.01×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CORT
CORT
MIAX
MIAX
Operating Cash FlowLast quarter
$38.4M
$120.8M
Free Cash FlowOCF − Capex
$38.4M
$102.2M
FCF MarginFCF / Revenue
19.0%
30.1%
Capex IntensityCapex / Revenue
0.0%
5.5%
Cash ConversionOCF / Net Profit
1.58×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CORT
CORT
MIAX
MIAX
Q4 25
$38.4M
Q3 25
$54.5M
$120.8M
Q2 25
$43.9M
Q1 25
$5.1M
Q4 24
$59.3M
Q3 24
$73.8M
Q2 24
$41.2M
Q1 24
$23.8M
Free Cash Flow
CORT
CORT
MIAX
MIAX
Q4 25
$38.4M
Q3 25
$102.2M
Q2 25
$43.9M
Q1 25
$5.0M
Q4 24
$59.2M
Q3 24
$72.2M
Q2 24
$40.8M
Q1 24
FCF Margin
CORT
CORT
MIAX
MIAX
Q4 25
19.0%
Q3 25
30.1%
Q2 25
22.6%
Q1 25
3.2%
Q4 24
32.5%
Q3 24
39.5%
Q2 24
24.9%
Q1 24
Capex Intensity
CORT
CORT
MIAX
MIAX
Q4 25
0.0%
Q3 25
0.0%
5.5%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.9%
Q2 24
0.3%
Q1 24
0.0%
Cash Conversion
CORT
CORT
MIAX
MIAX
Q4 25
1.58×
Q3 25
2.77×
Q2 25
1.25×
Q1 25
0.25×
Q4 24
1.93×
Q3 24
1.56×
Q2 24
1.16×
Q1 24
0.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CORT
CORT

Segment breakdown not available.

MIAX
MIAX

Transferred At Point In Time$246.7M73%
Transferred Over Time$29.9M9%
Access Fees$27.1M8%
Futures Segment$19.4M6%
Other$9.1M3%
TISEG$4.7M1%

Related Comparisons